Author

Matthew S. Jung

University of Tennessee Health Science CenterORCID 0009-0005-1700-4870Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Amelia Pi· 1 shared Audrey A. Birdwell· 1 shared Colleen Feng· 1 shared Jisun KangiD· 1 shared Junming Yue· 1 shared Lindsey J. Davis· 1 shared Rachel Patton McCordiD· 1 shared Rachel S. PerkinsiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amelia Pi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 2, 2026

Cancer stem cell transcriptomic signatures reveal patient-to-patient heterogeneity emphasizing the need for patient-specific ovarian cancer targets

Matthew S. Jung, Lindsey J. Davis, Audrey A. Birdwell…·Rachel S. Perkins

The paper identifies patient-specific transcriptomic signatures of ovarian cancer stem cells (CSCs) using RNA-seq, revealing isoform-level heterogeneity that drives stemness and drug resistance.

DOI 10.64898/2026.09.30.755773

humanbulk RNA-seq

𝕏 PostBluesky